Apricus Biosciences (APRI) Starts Presentation at LD Micro Main Event
Apricus Biosciences (NASDAQ: APRI) is a biopharmaceutical company that focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. Its lead product is Vitaros, a topically-applied cream formulation of alprostadil used for the treatment of erectile dysfunction. For more information, visit the company's website at www.apricusbio.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and…